Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

被引：0
|
作者：
ChangDong Lin
Yue Li
YueBin Zhang
ZhaoYuan Liu
Xia Mu
Chenjian Gu
Jing Liu
Yutang Li
GuoHui Li
JianFeng Chen
机构：
[1] University of Chinese Academy of Sciences,State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
[2] Chinese Academy of Sciences,State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics
[3] Fudan University,Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College
[4] BSL-3 laboratory of Fudan University,School of Life Science, Hangzhou Institute for Advanced Study
[5] School of Basic Medical Sciences,undefined
[6] Shanghai Medical College,undefined
[7] Fudan University,undefined
[8] University of Chinese Academy of Sciences,undefined
来源：
Signal Transduction and Targeted Therapy | / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Identification of potential novel inhibitors against the SARS-CoV-2 spike protein: targeting RBD and ACE2 interaction
    Verma, Jyoti
    Rath, Pragyan Parimita
    Gourinath, Samudrala
    Subbarao, Naidu
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2025, 43 (02): : 1027 - 1037
  • [22] Binding of SARS-CoV-2/SARS-CoV spike protein with human ACE2 receptor
    Koirala, Rajendra P.
    Thapa, Bidhya
    Khanal, Shyam P.
    Powrel, Jhulan
    Adhikari, Rajendra P.
    Adhikari, Narayan P.
    JOURNAL OF PHYSICS COMMUNICATIONS, 2021, 5 (03):
  • [23] In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment
    Sartore, Giovanni
    Bassani, Davide
    Ragazzi, Eugenio
    Traldi, Pietro
    Lapolla, Annunziata
    Moro, Stefano
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
    Cao, Wenpeng
    Dong, Chuqiao
    Kim, Seonghan
    Hou, Decheng
    Tai, Wanbo
    Du, Lanying
    Im, Wonpil
    Zhang, X. Frank
    BIOPHYSICAL JOURNAL, 2021, 120 (06) : 1011 - 1019
  • [25] In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment
    Giovanni Sartore
    Davide Bassani
    Eugenio Ragazzi
    Pietro Traldi
    Annunziata Lapolla
    Stefano Moro
    Scientific Reports, 11
  • [26] Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
    Lee, Myeongsang
    Major, Marian
    Hong, Huixiao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [27] Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2
    Wang, Wei-Jan
    Chen, Yeh
    Su, Wen-Chi
    Liu, Yen-Yi
    Shen, Wan-Jou
    Chang, Wei-Chao
    Huang, Sheng-Teng
    Lin, Cheng-Wen
    Wang, Yu-Chuan
    Yang, Chia-Shin
    Hou, Mei-Hui
    Chou, Yu-Chi
    Wu, Yang-Chang
    Wang, Shao-Chun
    Hung, Mien-Chie
    JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (10)
  • [28] CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
    Pei, Gaofeng
    Xu, Weifan
    Lan, Jun
    Wang, Xinquan
    Li, Pilong
    FUNDAMENTAL RESEARCH, 2022, 2 (04): : 562 - 569
  • [29] Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
    Benitez-Cardoza, Claudia Guadalupe
    Vique-Sanchez, Jose Luis
    LIFE SCIENCES, 2020, 256
  • [30] Soluble ACE2 in SARS-CoV-2 infection
    Yeung, M. L.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (5) : 297 - 297
12345